Search for: "Patent Docs"
Results 621 - 640
of 1,321
Sorted by Relevance
|
Sort by Date
1 May 2009, 9:00 am
(IAM) US: Johnson & Johnson – 5 year exclusivity period would kill incentives to innovate (Patent Docs) US: CHI CEO on patent reform and follow-on biologics legislation (Patent Docs) US: BIO urges Congress on patent reform: First, do no harm (Patent Baristas) US: Pharmaceutical advertising: How to use a domain name to circumvent application of law (Domain Name / Nom De Domaine!) [read post]
22 May 2017, 6:39 am
SAS Federal Circuit Decision SAS En Banc Denial SAS Petition SAS Federal Opposition SAS Reply Patent at Issue: US7110936 AIA Trial Docs: SAS IPR Petition IPR2013-00226.009 decision to institute IPR2013-00226 Final Decision IPR2013-00226 Rehearing Denial [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
15 Mar 2010, 3:38 am
Senate that would require that the false patent marking plaintiff have been harmed by the alleged false marking – check out a discussion of the provision at the Patent Docs. [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical… [read post]
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Mirapex (Pramipexole) – US: Mirapex case ends, Mylan Found to infringe Boehringer patent (Patent Docs) Moviprep (Polyethylene glycol) – US: Salix settles with Novel over Moviprep (IPBiz) Norvir (Ritonavir) – US: PUBPAT challenges eight of Abbott’s HIV/AIDS medicine patents (IP Watch) Strattera (Atomoxetine) – US: Eli Lilly granted 14-day injunction prohibiting production of… [read post]
16 Dec 2009, 3:39 am
(Patent Docs) (Patent Docs) US: Does the Patent Act include a written description requirement separate from the enablement requirement? [read post]
27 Oct 2010, 3:38 am
Abbott (EPLAW) Lunesta (Eszopiclone) – US: Cobalt Pharmaceuticals and Sepracor settle Lunesta patent litigation (Patent Docs) Mirapex (Pramipexole) – US: Mylan receives approval for generic version of Mirapex tablets (SmartBrief) Oracea (Doxycyline) – US: Mylan seeks declaratory judgment of non-infringement and invalidity based on ANDA filing: Mylan v Galderma (Patent Docs) Perlane, Restylane (Hyaluronic acid) – US: Genzyme files… [read post]
19 Feb 2008, 7:10 am
At this point, of course, Doc's has only cast doubt on the validity of the '994 patent. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat)… [read post]
7 Sep 2010, 6:10 pm
Perrigo Co (IPBiz) Norvir (Ritonavir) – US: Abbott’s HIV/AIDS drug patents challenged by PUBPAT (IP Watchdog) ReFacto (Moroctocog) and Xyntha (Antihemophilic factor) – US: Novartis drops one of three patents from ReFacto/Xyntha suit against Wyeth (Patent Docs) Strattera (Atomoxetine) – US: CAFC grants injunction pending disposition of Lilly v Actavis Elizabeth (Patent Docs) Valcyte (Valganciclovir) – US: Ranbaxy… [read post]
27 May 2009, 5:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Pfizer acquires rights to 55 generic pills, 20 injectibles through new deals with Claris Lifesciences and Aurobindo (GenericsWeb) Sytrinol (Polymethoxylated flavones, tocotrienols) – US: District Court N D Illinois rules patent co-owned by US not immunised from infringement or validity determinations (Patent… [read post]
27 Feb 2009, 5:00 am
(Patent Baristas) US: Teva releases second video in year of affordable healthcare campaign (SmartBrief) US: Discussion of NYT article ‘Crop Scientists Say Biotechnology Seed Companies are Thwarting Research’ (Patent Docs) (Patent Baristas) US FDA: Genetically engineered organisms can be patented (RelatIP) US: Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo seeks review and correction of patent term adjustment for… [read post]
28 Mar 2012, 10:00 pm
The authors, Donald Zuhn and Kevin Noonan, are partners at McDonnell Boehnen Hulbert & Berghoff, LLP, and contribute to Patent Docs on a daily basis. [read post]
28 Mar 2012, 10:00 pm
The authors, Donald Zuhn and Kevin Noonan, are partners at McDonnell Boehnen Hulbert & Berghoff, LLP, and contribute to Patent Docs on a daily basis. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch)… [read post]
19 Aug 2009, 5:41 am
(Patent Docs) US: BIO files amicus brief in Bilski (Patent Docs) US: Jim Greenwood on data exclusivity and healthcare innovation (BiotechBlog) (IP Watchdog) (Patent Docs) US: European biosimilars market may hint at limited US threat (GenericsWeb) US: Chris Hansen on the Myriad lawsuit (Patents4Life) Products Effexor (Venlafaxine) – US: Wyeth files suit alleging Alphapharm’s Enlafax infringes its Venlafaxine… [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs) Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
30 Jun 2010, 5:52 am
(Patent Docs) [read post]
